Statin use and thyroid cancer: A population-based case-control study

Clinical Endocrinology

Volumn 83, Issue 1, 2015, Pages 111-116

  Hung, Shih Han ^a   Lin, Herng Ching ^b,c   Chung, Shiu Dong ^b,d  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; PRESCRIPTION DRUG; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HYPERLIPIDEMIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; TAIWAN; THYROID CANCER; CASE CONTROL STUDY; FACTUAL DATABASE; HYPERLIPIDEMIAS; RISK FACTOR; STATISTICAL MODEL; THYROID NEOPLASMS;

ADULT; AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TAIWAN; THYROID NEOPLASMS;

EID: 84932095774     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12570     Document Type: Article

References (31)

1. Prospective Studies Collaboration, Lewington, S., Whitlock, G., et al,. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 370, 1829-1839.
2. Goldstein, J.L., Hazzard, W.R., Schrott, H.G., et al,. (1973) Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. The Journal of Clinical Investigation, 52, 1533-1543.
3. Cohn, P.F., Gabbay, S.I., &, Weglicki, W.B., (1976) Serum lipid levels in angiographically defined coronary artery disease. Annals of Internal Medicine, 84, 241-245.
4. Taylor, F., Ward, K., Moore, T.H., et al,. (2011) Statins for the primary prevention of cardiovascular disease. The Cochrane Database of Systematic Reviews, CD004816.
5. Chang, C.H., Lee, Y.C., Tsai, C.T., et al,. (2014) Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease. Atherosclerosis, 232, 224-230.
6. Kawahara, T., Nishikawa, M., Kawahara, C., et al,. (2013) Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. Circulation, 127, 2327-2335.
7. Taylor, F., Huffman, M.D., Macedo, A.F., et al,. (2013) Statins for the primary prevention of cardiovascular disease. The Cochrane Database of Systematic Reviews, 1, CD004816.
8. Friis, S., Poulsen, A.H., Johnsen, S.P., et al,. (2005) Cancer risk among statin users: a population-based cohort study. International Journal of Cancer, 114, 643-647.
9. Graaf, M.R., Beiderbeck, A.B., Egberts, A.C., et al,. (2004) The risk of cancer in users of statins. Journal of Clinical Oncology, 22, 2388-2394.
10. Karp, I., Behlouli, H., Lelorier, J., et al,. (2008) Statins and cancer risk. American Journal of Medicine, 121, 302-309.
11. Poynter, J.N., Gruber, S.B., Higgins, P.D., et al,. (2005) Statins and the risk of colorectal cancer. The New England Journal of Medicine, 352, 2184-2192.
12. McDougall, J.A., Malone, K.E., Daling, J.R., et al,. (2013) Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiology, Biomarkers & Prevention, 22, 1529-1537.
13. Lutski, M., Shalev, V., Porath, A., et al,. (2012) Continuation with statin therapy and the risk of primary cancer: a population-based study. Preventing Chronic Disease, 9, E137.
14. Platz, E.A., Leitzmann, M.F., Visvanathan, K., et al,. (2006) Statin drugs and risk of advanced prostate cancer. Journal of the National Cancer Institute, 98, 1819-1825.
15. Dale, K.M., Coleman, C.I., Henyan, N.N., et al,. (2006) Statins and cancer risk: a meta-analysis. Journal of American Medical Association, 295, 74-80.
16. Cholesterol Treatment Trialists, Emberson, J.R., Kearney, P.M., et al,. (2012) Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One, 7, e29849.
17. Blais, L., Desgagne, A., &, LeLorier, J., (2000) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Archives of Internal Medicine, 160, 2363-2368.
18. Kaye, J.A., &, Jick, H., (2004) Statin use and cancer risk in the General Practice Research Database. British Journal of Cancer, 90, 635-637.
19. Kaye, J.A., Meier, C.R., Walker, A.M., et al,. (2002) Statin use, hyperlipidaemia, and the risk of breast cancer. British Journal of Cancer, 86, 1436-1439.
20. Lee, T.H., (2001) By the way, doctor.I've heard that statins can cause cancer, at least in animal experiments. Is there any chance that my statin might prevent another heart attack in the short run, but give me cancer in the long run? Harvard Health Letter, 26, 8.
21. Coogan, P.F., Rosenberg, L., Palmer, J.R., et al,. (2002) Statin use and the risk of breast and prostate cancer. Epidemiology, 13, 262-267.
22. Bjerre, L.M., &, LeLorier, J., (2001) Do statins cause cancer? A meta-analysis of large randomized clinical trials. American Journal of Medicine, 110, 716-723.
23. Keyomarsi, K., Sandoval, L., Band, V., et al,. (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Research, 51, 3602-3609.
24. Rao, S., Porter, D.C., Chen, X., et al,. (1999) Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proceedings of the National Academy of Sciences of the United States of America, 96, 7797-7802.
25. Addeo, R., Altucci, L., Battista, T., et al,. (1996) Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors. Biochemical and Biophysical Research Communications, 220, 864-870.
26. Muck, A.O., Seeger, H., &, Wallwiener, D., (2004) Inhibitory effect of statins on the proliferation of human breast cancer cells. International Journal of Clinical Pharmacology and Therapeutics, 42, 695-700.
27. Santin, A.P., &, Furlanetto, T.W., (2011) Role of estrogen in thyroid function and growth regulation. Journal of Thyroid Research, 2011, 875125.
28. Manole, D., Schildknecht, B., Gosnell, B., et al,. (2001) Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. The Journal of Clinical Endocrinology and Metabolism, 86, 1072-1077.
29. Zahid, M., Goldner, W., Beseler, C.L., et al,. (2013) Unbalanced estrogen metabolism in thyroid cancer. International Journal of Cancer, 133, 2642-2649.
30. Kwak, B., Mulhaupt, F., Myit, S., et al,. (2000) Statins as a newly recognized type of immunomodulator. Nature Medicine, 6, 1399-1402.
31. Jacobs, D., Blackburn, H., Higgins, M., et al,. (1992) Report of the conference on low blood cholesterol: mortality associations. Circulation, 86, 1046-1060.